GFM
LFCR icon

GF Fund Management’s Lifecore Biomedical LFCR Stock Holding History

GF Fund Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09K Sell
779
-57
-7% -$287 ﹤0.01% 578
2026
Q1 		$3.11K Buy
836
+100
+14% +$690 ﹤0.01% 615
2025
Q4 		$6.02K Buy
+736
New +$5.45K ﹤0.01% 613

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

GF Fund Management's LFCR Position: Q2 2026 in Review

GF Fund Management reduced its Lifecore Biomedical (LFCR) stake by 6.8% in Q2 2026, selling an estimated $287 and leaving 779 shares worth $4.09K. The position accounts for ﹤0.01% of the portfolio, ranked #578.

GF Fund Management first reported a position in LFCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.02K in Q4 2025. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • GF Fund Management held 779 shares of Lifecore Biomedical worth $4.09K as of Q2 2026.
  • GF Fund Management sold 57 Lifecore Biomedical shares in Q2 2026, an estimated $287.
  • Lifecore Biomedical made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #578 holding.
  • GF Fund Management first reported a position in Lifecore Biomedical in Q4 2025 and has held it in 3 quarters since.
  • GF Fund Management's Lifecore Biomedical position peaked at $6.02K in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.